Posted in | News | Chemical Sensor

Implant Sciences’ QS-B220 Desktop Explosives Trace Detector to be Demonstrated at Miami International Airport

Implant Sciences Corporation , a high technology supplier of systems and sensors for homeland security and defense markets, announced today the Company will host explosives trace detection briefings and demonstrations of its TSA-approved QS-B220 desktop explosives trace detector at the Miami International Airport on Thursday, September 19, 2013, in the Miami-International Airport West Cargo Area Conference Room - Cargo Building 702, Suite #205.

The event is open to individuals involved in air cargo security. Please contact [email protected] for information on how to attend.

"Explosive Trace Detection (ETD) is arguably the best air cargo security technology available today. Important changes are coming when the TSA's grandfathered list of legacy ETD systems lose their approved status on January 1, 2014. This event will provide important information for air cargo facilities looking to replace expiring systems or expand screening operations," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.

About the QS-B220 Desktop Explosives Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences

Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to currently have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 handheld explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA approval for air cargo screening, the Company's QS-B220 has also received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    L3Harris Technologies, Inc.. (2019, February 24). Implant Sciences’ QS-B220 Desktop Explosives Trace Detector to be Demonstrated at Miami International Airport. AZoSensors. Retrieved on November 21, 2024 from https://www.azosensors.com/news.aspx?newsID=6606.

  • MLA

    L3Harris Technologies, Inc.. "Implant Sciences’ QS-B220 Desktop Explosives Trace Detector to be Demonstrated at Miami International Airport". AZoSensors. 21 November 2024. <https://www.azosensors.com/news.aspx?newsID=6606>.

  • Chicago

    L3Harris Technologies, Inc.. "Implant Sciences’ QS-B220 Desktop Explosives Trace Detector to be Demonstrated at Miami International Airport". AZoSensors. https://www.azosensors.com/news.aspx?newsID=6606. (accessed November 21, 2024).

  • Harvard

    L3Harris Technologies, Inc.. 2019. Implant Sciences’ QS-B220 Desktop Explosives Trace Detector to be Demonstrated at Miami International Airport. AZoSensors, viewed 21 November 2024, https://www.azosensors.com/news.aspx?newsID=6606.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.